US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist
  • 2.370
  • +0.180+8.22%
Close Dec 2 16:00 ET
  • 2.360
  • -0.010-0.41%
Post 19:56 ET
214.61MMarket Cap-1427P/E (TTM)

Caribou Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-32.59%228.18M
0.93%261.65M
28.64%293.99M
32.77%328.83M
32.77%328.83M
15.38%338.49M
-23.74%259.23M
-35.39%228.54M
-34.10%247.66M
-34.10%247.66M
-Cash and cash equivalents
-69.28%31.97M
-42.80%37.87M
-6.34%49.4M
-12.30%51.16M
-12.30%51.16M
26.77%104.06M
-40.98%66.19M
-64.27%52.74M
-75.73%58.34M
-75.73%58.34M
-Short-term investments
-16.30%196.21M
15.93%223.78M
39.13%244.59M
46.66%277.67M
46.66%277.67M
10.95%234.43M
-15.25%193.04M
-14.70%175.79M
39.81%189.33M
39.81%189.33M
Receivables
-48.11%2.67M
-22.07%2.92M
-25.38%3.61M
-17.26%3.86M
-17.26%3.86M
2.82%5.14M
-34.48%3.74M
-19.79%4.84M
-42.59%4.66M
-42.59%4.66M
-Accounts receivable
-83.76%184K
-71.93%215K
-40.18%917K
-26.73%148K
-26.73%148K
185.39%1.13M
46.18%766K
309.89%1.53M
-82.48%202K
-82.48%202K
-Accrued interest receivable
37.57%747K
193.82%808K
98.19%658K
23.16%702K
23.16%702K
8.82%543K
-52.09%275K
-23.85%332K
152.21%570K
152.21%570K
-Other receivables
-49.88%1.73M
-29.91%1.89M
-31.54%2.04M
-22.69%3.01M
-22.69%3.01M
-15.59%3.46M
-41.45%2.7M
-43.05%2.98M
-42.30%3.89M
-42.30%3.89M
Prepaid assets
-19.77%4.38M
-3.58%3.93M
3.92%5.07M
-27.45%4.94M
-27.45%4.94M
-26.79%5.46M
-30.66%4.08M
-32.99%4.88M
3.61%6.8M
3.61%6.8M
Other current assets
36.81%2.2M
60.54%2.38M
49.59%1.85M
9.03%1.22M
9.03%1.22M
46.06%1.61M
5.32%1.49M
27.74%1.23M
66.77%1.12M
66.77%1.12M
Total current assets
-32.30%237.43M
0.87%270.88M
27.15%304.51M
30.20%338.84M
30.20%338.84M
14.26%350.69M
-23.91%268.54M
-34.92%239.49M
-33.47%260.25M
-33.47%260.25M
Non current assets
Net PPE
1.99%40.06M
6.15%41.01M
12.28%40.83M
15.88%40.45M
15.88%40.45M
16.95%39.28M
16.17%38.64M
14.47%36.36M
614.30%34.91M
614.30%34.91M
-Gross PPE
8.77%51.87M
13.66%51.67M
19.05%50.68M
22.29%49.6M
22.29%49.6M
23.00%47.68M
19.67%45.46M
17.76%42.57M
352.44%40.56M
352.44%40.56M
-Accumulated depreciation
-40.48%-11.81M
-56.21%-10.66M
-58.71%-9.85M
-61.87%-9.14M
-61.87%-9.14M
-62.23%-8.41M
-44.22%-6.83M
-41.60%-6.21M
-38.56%-5.65M
-38.56%-5.65M
Investments and advances
-5.87%62.11M
44.71%59.41M
-14.89%59.69M
-33.40%51.33M
-33.40%51.33M
15.80%65.98M
21.18%41.06M
56.70%70.14M
70.13%77.07M
70.13%77.07M
Other non current assets
202.36%4.74M
15.29%1.64M
21.54%1.79M
3.12%1.59M
3.12%1.59M
17.37%1.57M
8.90%1.42M
0.82%1.48M
57.74%1.54M
57.74%1.54M
Total non current assets
0.07%106.91M
25.83%102.06M
-5.24%102.31M
-17.75%93.37M
-17.75%93.37M
16.24%106.83M
18.51%81.11M
38.45%107.97M
121.87%113.52M
121.87%113.52M
Total assets
-24.74%344.33M
6.66%372.94M
17.08%406.83M
15.64%432.21M
15.64%432.21M
14.72%457.52M
-17.02%349.65M
-22.09%347.46M
-15.51%373.77M
-15.51%373.77M
Liabilities
Current liabilities
Payables
13.76%2.7M
-27.21%3.23M
124.07%5.94M
172.25%3.12M
172.25%3.12M
93.57%2.38M
940.61%4.43M
46.14%2.65M
-71.28%1.15M
-71.28%1.15M
-accounts payable
13.76%2.7M
-27.21%3.23M
124.07%5.94M
172.25%3.12M
172.25%3.12M
93.57%2.38M
940.61%4.43M
46.14%2.65M
-71.28%1.15M
-71.28%1.15M
Current accrued expenses
75.71%17.39M
73.86%15.56M
72.64%13.24M
17.36%10.51M
17.36%10.51M
21.84%9.9M
-6.27%8.95M
-3.08%7.67M
10.27%8.96M
10.27%8.96M
Current debt and capital lease obligation
3.42%1.18M
16.96%1.26M
23.68%1.26M
24.22%1.2M
24.22%1.2M
24.89%1.14M
23.03%1.08M
23.88%1.02M
--966K
--966K
-Current capital lease obligation
3.42%1.18M
16.96%1.26M
23.68%1.26M
24.22%1.2M
24.22%1.2M
24.89%1.14M
23.03%1.08M
23.88%1.02M
--966K
--966K
Current deferred liabilities
0.11%2.83M
-78.17%2.83M
-74.02%2.83M
-71.35%2.85M
-71.35%2.85M
-76.52%2.83M
2.53%12.96M
-15.23%10.88M
14.18%9.94M
14.18%9.94M
Other current liabilities
-40.89%973K
-17.70%1.58M
-21.54%1.3M
-19.27%1.11M
-19.27%1.11M
-12.68%1.65M
10.66%1.92M
107.13%1.66M
73.86%1.37M
73.86%1.37M
Current liabilities
30.88%32.16M
-9.98%30.94M
7.09%29.02M
0.62%28.3M
0.62%28.3M
-14.72%24.57M
19.13%34.38M
1.62%27.1M
8.90%28.13M
8.90%28.13M
Non current liabilities
Long term debt and capital lease obligation
-3.24%25.46M
-2.40%25.53M
-1.92%25.9M
-3.26%25.91M
-3.26%25.91M
-2.38%26.32M
-3.45%26.16M
-3.07%26.4M
--26.78M
--26.78M
-Long term capital lease obligation
-3.24%25.46M
-2.40%25.53M
-1.92%25.9M
-3.26%25.91M
-3.26%25.91M
-2.38%26.32M
-3.45%26.16M
-3.07%26.4M
--26.78M
--26.78M
Non current deferred liabilities
-36.64%4.5M
-72.17%5.16M
-58.13%5.98M
-59.23%6.66M
-59.23%6.66M
-55.28%7.11M
15.16%18.54M
-19.71%14.29M
-33.61%16.34M
-33.61%16.34M
Other non current liabilities
-19.98%1.01M
-24.71%841K
88.83%2.64M
78.01%2.94M
78.01%2.94M
-58.67%1.26M
-22.00%1.12M
-44.00%1.4M
-59.70%1.65M
-59.70%1.65M
Total non current liabilities
-10.69%30.97M
-31.18%31.53M
-18.00%34.52M
-20.69%35.51M
-20.69%35.51M
-24.43%34.68M
2.67%45.81M
-11.45%42.09M
55.97%44.77M
55.97%44.77M
Total liabilities
6.54%63.13M
-22.09%62.47M
-8.17%63.54M
-12.46%63.81M
-12.46%63.81M
-20.69%59.25M
9.13%80.19M
-6.75%69.19M
33.67%72.89M
33.67%72.89M
Shareholders'equity
Share capital
12.50%9K
50.00%9K
50.00%9K
33.33%8K
33.33%8K
33.33%8K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
-common stock
12.50%9K
50.00%9K
50.00%9K
33.33%8K
33.33%8K
33.33%8K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
-Preferred stock
----
----
----
----
----
--0
--0
--0
----
----
Retained earnings
-55.94%-412.9M
-48.45%-378.22M
-51.17%-340.52M
-51.76%-299.29M
-51.76%-299.29M
-55.55%-264.78M
-77.45%-254.78M
-92.72%-225.26M
-101.66%-197.22M
-101.66%-197.22M
Paid-in capital
4.41%693.31M
31.14%688.99M
35.67%684.12M
33.64%667.65M
33.64%667.65M
33.78%664.02M
6.56%525.37M
2.96%504.26M
2.85%499.6M
2.85%499.6M
Gains losses not affecting retained earnings
180.43%789K
71.92%-319K
55.89%-322K
101.98%30K
101.98%30K
51.79%-981K
28.15%-1.14M
32.97%-730K
-1,024.44%-1.52M
-1,024.44%-1.52M
Total stockholders'equity
-29.39%281.2M
15.22%310.46M
23.36%343.29M
22.44%368.4M
22.44%368.4M
22.88%398.27M
-22.54%269.46M
-25.15%278.27M
-22.42%300.87M
-22.42%300.87M
Total equity
-29.39%281.2M
15.22%310.46M
23.36%343.29M
22.44%368.4M
22.44%368.4M
22.88%398.27M
-22.54%269.46M
-25.15%278.27M
-22.42%300.87M
-22.42%300.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -32.59%228.18M0.93%261.65M28.64%293.99M32.77%328.83M32.77%328.83M15.38%338.49M-23.74%259.23M-35.39%228.54M-34.10%247.66M-34.10%247.66M
-Cash and cash equivalents -69.28%31.97M-42.80%37.87M-6.34%49.4M-12.30%51.16M-12.30%51.16M26.77%104.06M-40.98%66.19M-64.27%52.74M-75.73%58.34M-75.73%58.34M
-Short-term investments -16.30%196.21M15.93%223.78M39.13%244.59M46.66%277.67M46.66%277.67M10.95%234.43M-15.25%193.04M-14.70%175.79M39.81%189.33M39.81%189.33M
Receivables -48.11%2.67M-22.07%2.92M-25.38%3.61M-17.26%3.86M-17.26%3.86M2.82%5.14M-34.48%3.74M-19.79%4.84M-42.59%4.66M-42.59%4.66M
-Accounts receivable -83.76%184K-71.93%215K-40.18%917K-26.73%148K-26.73%148K185.39%1.13M46.18%766K309.89%1.53M-82.48%202K-82.48%202K
-Accrued interest receivable 37.57%747K193.82%808K98.19%658K23.16%702K23.16%702K8.82%543K-52.09%275K-23.85%332K152.21%570K152.21%570K
-Other receivables -49.88%1.73M-29.91%1.89M-31.54%2.04M-22.69%3.01M-22.69%3.01M-15.59%3.46M-41.45%2.7M-43.05%2.98M-42.30%3.89M-42.30%3.89M
Prepaid assets -19.77%4.38M-3.58%3.93M3.92%5.07M-27.45%4.94M-27.45%4.94M-26.79%5.46M-30.66%4.08M-32.99%4.88M3.61%6.8M3.61%6.8M
Other current assets 36.81%2.2M60.54%2.38M49.59%1.85M9.03%1.22M9.03%1.22M46.06%1.61M5.32%1.49M27.74%1.23M66.77%1.12M66.77%1.12M
Total current assets -32.30%237.43M0.87%270.88M27.15%304.51M30.20%338.84M30.20%338.84M14.26%350.69M-23.91%268.54M-34.92%239.49M-33.47%260.25M-33.47%260.25M
Non current assets
Net PPE 1.99%40.06M6.15%41.01M12.28%40.83M15.88%40.45M15.88%40.45M16.95%39.28M16.17%38.64M14.47%36.36M614.30%34.91M614.30%34.91M
-Gross PPE 8.77%51.87M13.66%51.67M19.05%50.68M22.29%49.6M22.29%49.6M23.00%47.68M19.67%45.46M17.76%42.57M352.44%40.56M352.44%40.56M
-Accumulated depreciation -40.48%-11.81M-56.21%-10.66M-58.71%-9.85M-61.87%-9.14M-61.87%-9.14M-62.23%-8.41M-44.22%-6.83M-41.60%-6.21M-38.56%-5.65M-38.56%-5.65M
Investments and advances -5.87%62.11M44.71%59.41M-14.89%59.69M-33.40%51.33M-33.40%51.33M15.80%65.98M21.18%41.06M56.70%70.14M70.13%77.07M70.13%77.07M
Other non current assets 202.36%4.74M15.29%1.64M21.54%1.79M3.12%1.59M3.12%1.59M17.37%1.57M8.90%1.42M0.82%1.48M57.74%1.54M57.74%1.54M
Total non current assets 0.07%106.91M25.83%102.06M-5.24%102.31M-17.75%93.37M-17.75%93.37M16.24%106.83M18.51%81.11M38.45%107.97M121.87%113.52M121.87%113.52M
Total assets -24.74%344.33M6.66%372.94M17.08%406.83M15.64%432.21M15.64%432.21M14.72%457.52M-17.02%349.65M-22.09%347.46M-15.51%373.77M-15.51%373.77M
Liabilities
Current liabilities
Payables 13.76%2.7M-27.21%3.23M124.07%5.94M172.25%3.12M172.25%3.12M93.57%2.38M940.61%4.43M46.14%2.65M-71.28%1.15M-71.28%1.15M
-accounts payable 13.76%2.7M-27.21%3.23M124.07%5.94M172.25%3.12M172.25%3.12M93.57%2.38M940.61%4.43M46.14%2.65M-71.28%1.15M-71.28%1.15M
Current accrued expenses 75.71%17.39M73.86%15.56M72.64%13.24M17.36%10.51M17.36%10.51M21.84%9.9M-6.27%8.95M-3.08%7.67M10.27%8.96M10.27%8.96M
Current debt and capital lease obligation 3.42%1.18M16.96%1.26M23.68%1.26M24.22%1.2M24.22%1.2M24.89%1.14M23.03%1.08M23.88%1.02M--966K--966K
-Current capital lease obligation 3.42%1.18M16.96%1.26M23.68%1.26M24.22%1.2M24.22%1.2M24.89%1.14M23.03%1.08M23.88%1.02M--966K--966K
Current deferred liabilities 0.11%2.83M-78.17%2.83M-74.02%2.83M-71.35%2.85M-71.35%2.85M-76.52%2.83M2.53%12.96M-15.23%10.88M14.18%9.94M14.18%9.94M
Other current liabilities -40.89%973K-17.70%1.58M-21.54%1.3M-19.27%1.11M-19.27%1.11M-12.68%1.65M10.66%1.92M107.13%1.66M73.86%1.37M73.86%1.37M
Current liabilities 30.88%32.16M-9.98%30.94M7.09%29.02M0.62%28.3M0.62%28.3M-14.72%24.57M19.13%34.38M1.62%27.1M8.90%28.13M8.90%28.13M
Non current liabilities
Long term debt and capital lease obligation -3.24%25.46M-2.40%25.53M-1.92%25.9M-3.26%25.91M-3.26%25.91M-2.38%26.32M-3.45%26.16M-3.07%26.4M--26.78M--26.78M
-Long term capital lease obligation -3.24%25.46M-2.40%25.53M-1.92%25.9M-3.26%25.91M-3.26%25.91M-2.38%26.32M-3.45%26.16M-3.07%26.4M--26.78M--26.78M
Non current deferred liabilities -36.64%4.5M-72.17%5.16M-58.13%5.98M-59.23%6.66M-59.23%6.66M-55.28%7.11M15.16%18.54M-19.71%14.29M-33.61%16.34M-33.61%16.34M
Other non current liabilities -19.98%1.01M-24.71%841K88.83%2.64M78.01%2.94M78.01%2.94M-58.67%1.26M-22.00%1.12M-44.00%1.4M-59.70%1.65M-59.70%1.65M
Total non current liabilities -10.69%30.97M-31.18%31.53M-18.00%34.52M-20.69%35.51M-20.69%35.51M-24.43%34.68M2.67%45.81M-11.45%42.09M55.97%44.77M55.97%44.77M
Total liabilities 6.54%63.13M-22.09%62.47M-8.17%63.54M-12.46%63.81M-12.46%63.81M-20.69%59.25M9.13%80.19M-6.75%69.19M33.67%72.89M33.67%72.89M
Shareholders'equity
Share capital 12.50%9K50.00%9K50.00%9K33.33%8K33.33%8K33.33%8K0.00%6K0.00%6K0.00%6K0.00%6K
-common stock 12.50%9K50.00%9K50.00%9K33.33%8K33.33%8K33.33%8K0.00%6K0.00%6K0.00%6K0.00%6K
-Preferred stock ----------------------0--0--0--------
Retained earnings -55.94%-412.9M-48.45%-378.22M-51.17%-340.52M-51.76%-299.29M-51.76%-299.29M-55.55%-264.78M-77.45%-254.78M-92.72%-225.26M-101.66%-197.22M-101.66%-197.22M
Paid-in capital 4.41%693.31M31.14%688.99M35.67%684.12M33.64%667.65M33.64%667.65M33.78%664.02M6.56%525.37M2.96%504.26M2.85%499.6M2.85%499.6M
Gains losses not affecting retained earnings 180.43%789K71.92%-319K55.89%-322K101.98%30K101.98%30K51.79%-981K28.15%-1.14M32.97%-730K-1,024.44%-1.52M-1,024.44%-1.52M
Total stockholders'equity -29.39%281.2M15.22%310.46M23.36%343.29M22.44%368.4M22.44%368.4M22.88%398.27M-22.54%269.46M-25.15%278.27M-22.42%300.87M-22.42%300.87M
Total equity -29.39%281.2M15.22%310.46M23.36%343.29M22.44%368.4M22.44%368.4M22.88%398.27M-22.54%269.46M-25.15%278.27M-22.42%300.87M-22.42%300.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.28%